KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Total Debt Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.89%
Dec 31, 2025 10.61%
Sep 30, 2025 9.75%
Jun 30, 2025 10.43%
Mar 31, 2025 12.50%
Dec 31, 2024 14.98%
Sep 30, 2024 15.18%
Jun 30, 2024 15.40%
Mar 31, 2024 14.16%
Dec 31, 2023 13.75%
Sep 30, 2023 11.92%
Jun 30, 2023 12.27%
Mar 31, 2023 11.63%
Dec 31, 2022 1.96%
Sep 30, 2022 1.59%
Jun 30, 2022 0.82%
Mar 31, 2022 1.57%
Dec 31, 2021 -0.76%
Sep 30, 2021 1.25%
Jun 30, 2021 -0.27%
Mar 31, 2021 -0.96%
Dec 31, 2020 0.97%
Sep 30, 2020 1.54%
Jun 30, 2020 1.38%
Mar 31, 2020 0.97%
Dec 31, 2019 -0.53%
Sep 30, 2019 -2.01%
Jun 30, 2019 -1.68%
Mar 31, 2019 2.27%
Dec 31, 2018 1.10%
Sep 30, 2018 4.84%
Jun 30, 2018 7.61%
Mar 31, 2018 8.27%
Dec 31, 2017 8.02%
Sep 30, 2017 8.29%
Dec 31, 2016 10.14%
Mar 31, 2015 26.24%
Dec 31, 2014 38.22%
Sep 30, 2014 40.20%
Jun 30, 2014 40.50%